ロード中...
How I manage frontline transplant-eligible multiple myeloma in Italy
The treatment of transplant-eligible multiple myeloma patients in Italy consists in an induction phase based on bortezomib plus thalidomide plus dexamethasone (VTd), followed by a single or tandem autologous stem cell transplantation (ASCT), followed by lenalidomide maintenance. This approach offers...
保存先:
| 出版年: | Hematol Rep |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
PAGEPress Publications, Pavia, Italy
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7520856/ https://ncbi.nlm.nih.gov/pubmed/33042503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2020.8954 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|